Viral hepatitis

Area of Science:

• Virology
• Hepatology
• Infectious Diseases

Background:

• The spectrum of hepatitis viruses has expanded to include types A through G.
• Hepatitis viruses exhibit diverse transmission routes, incubation periods, and clinical outcomes, ranging from acute to chronic illness.
• Prevention strategies, including vaccination, are crucial for managing hepatitis infections.

Purpose of the Study:

• To provide an overview of the different hepatitis viruses (A-G).
• To describe the characteristics, transmission, and health implications of each hepatitis virus.
• To highlight the current and emerging prevention and management strategies for viral hepatitis.

Main Methods:

• Literature review and synthesis of existing knowledge on hepatitis viruses A-G.
• Description of viral properties: genetic material (RNA/DNA), incubation period, and transmission routes (e.g., oro-fecal, blood-borne).
• Summary of clinical manifestations, including acute/chronic illness, potential for liver cancer, and fatality rates.

Main Results:

• Hepatitis A virus (HAV): RNA, short incubation, oro-fecal transmission, non-chronic, preventable by vaccine.
• Hepatitis B virus (HBV): DNA, long incubation, blood-borne, causes chronic illness and liver cancer, preventable by vaccine (global infant vaccination recommended).
• Hepatitis C virus (HCV): RNA, parenterally transmitted, causes chronic illness and liver cancer, a major cause of post-transfusion hepatitis.
• Hepatitis Delta virus (HDV): Defective, requires HBV for replication, affecting only HBV-infected individuals.
• Hepatitis E virus (HEV): RNA, enterically transmitted, generally non-chronic, endemic in certain regions.
• Hepatitis G virus (HGV): Newly described, further information pending.

Conclusions:

• The growing list of hepatitis viruses necessitates a comprehensive understanding of their distinct epidemiological and clinical profiles.
• Vaccination remains a cornerstone for preventing Hepatitis A and B, with global HBV vaccination being a key public health initiative.
• Hepatitis C poses a significant burden, particularly post-transfusion, while Hepatitis D is dependent on HBV infection. Hepatitis E is primarily an enteric concern, and Hepatitis G requires further investigation.